Last reviewed · How we verify
NCT05309018: LAMIPA
Implantation of an Advanced Practice Nurse in the Complex Care Pathway of Patients With AML
trial testing Interviews in Myeloid Leukemia. Withdrawn.
15 August 2024
Quick facts
| Lead sponsor | Centre Hospitalier Régional Metz-Thionville |
|---|---|
| Status | Withdrawn |
| Study type | OBSERVATIONAL |
| Start date | 15 May 2024 |
| Primary completion | 15 August 2024 |
| Estimated completion | 15 December 2024 |
Drugs / interventions tested
- Interviews
Conditions studied
- Myeloid Leukemia — all drugs for Myeloid Leukemia →
Sponsor
Centre Hospitalier Régional Metz-Thionville
Who can join
18 and older, any sex, with Myeloid Leukemia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Advanced Practice Nurse (APN) is a new contributor in the French healthcare system. APN is part of a multidisciplinary team and aim to monitor patients under the coordination of the doctor particularly in onco-hematology. The aim of the study is to describe the different perceptions and expectations of APN monitoring according to patients with acute myeloid leukemia (AML) and their care team. This study will involve 10 patients, recruited over a provisional period of 5 months and 25 member of care team. Patients and their care team will be asked about their perceptions and expectations of APN participation in (AML monitoring) during a semi-structured interviews.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05309018
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Interviews
Trials testing the same drug.
- NCT07105020 — iCCARE Project #4: Grounded Theory Study of the Social Determinants of Migrant Health Factors Impacting Prostate Cancer · NA · not yet recruiting
- NCT07105046 — Facilitators and Barriers to Cancer Treatment Among Texas Residents · NA · not yet recruiting
- NCT07129590 — Trauma-Informed Care for Smoking Cessation for Pregnancy · NA · recruiting
- NCT07158983 — Evaluation of a Child Health Care Program for Early Identification of Family Violence · not yet recruiting
- NCT07142005 — Cultural Adaptation of an Educational Tool in Medullary Thyroid Cancer · recruiting
Other recruiting trials for Myeloid Leukemia
Currently open trials in the same condition.
- NCT06235801 — A Phase I/II Study of Gilteritinib and Momelotinib for Patients With Relapsed or Refractory FLT3-Mutated Acute Myeloid L · Phase 1, PHASE2 · recruiting
- NCT06130579 — Interferon-α for TP53 Myeloid Malignancy Post Allo-HSCT · Phase 2 · recruiting
- NCT05194397 — Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors · Phase 2 · recruiting
- NCT05035706 — Anti-Leukemia Immune Responses After Irradiation of Extramedullary Tumors · EARLY_PHASE1 · active not recruiting
- NCT04260022 — Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL · Phase 1 · recruiting
Other Centre Hospitalier Régional Metz-Thionville trials
Trials by the same sponsor.
- NCT07435389 — VENTILATION DURING SPACEFLIGHT (PHASE 2) · NA · not yet recruiting
- NCT07405996 — Referral of Patients With Biological Abnormalities to an Emergency Department · not yet recruiting
- NCT07406022 — Optical Characterization and Multi-modality, Multi-scale Modeling of Human Skin Applied to Cancer Diagnosis. · not yet recruiting
- NCT07515404 — A New Multimodal and Semi-specific Therapeutic Plasmapheresis Concept, a Case Series Study · completed
- NCT07390604 — Case Series : Management of Elevated Lipoprotein(a) Using Double-Filtration Plasmapheresis (DFPP) in Hemodialysis Patien · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05309018 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Régional Metz-Thionville
- Last refreshed: 23 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05309018.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing